bry812
mAbexperimentalADC
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2023 (NCT06038058)
Timeline
Indications
Studied for
Mechanism of action
- Zinc transporter ZIP6BINDING AGENT
binding agent - SLC39A6
Chemistry & pharmacology
- Payload
- unclear
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07311538 | Phase 2 | Dec 31, 2025 | Shanghai Bioray Laboratory Inc. |
| NCT06038058 | Phase 1 | Oct 31, 2023 | Shanghai Bioray Laboratory Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shanghai Bioray Laboratory Inc. | For profit | 2 | 2 | 2 | 2023 |
1 organizations
Page 1 / 1